Director Rawcliffe Adrian sold $67,183 worth of shares (12,700 units at $5.29) as part of a pre-agreed trading plan, closing all direct ownership in the company (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

WVE· Wave Life Sciences Ltd.

Health Care

Original source

Director Rawcliffe Adrian sold $67,183 worth of shares (12,700 units at $5.29) as part of a pre-agreed trading plan, closing all direct ownership in the company (SEC Form 4) | Quantisnow